<DOC>
	<DOCNO>NCT00396721</DOCNO>
	<brief_summary>The purpose study test pilot trial efficacy tolerance sirolimus oral ( low dos ) patient treat poor-prognosis IgA Nephropathy .</brief_summary>
	<brief_title>Sirolimus Therapy Poor Prognosis Immunoglobulin A Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Glomerulonephritis</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Age 18 70 capacity grant inform consent Biopsyproven IgA nephropathy mean standard immunohistochemical morphological criterion Renal biopsy 3 month prior randomization date Absence know hepatic , cardiac , pulmonary intestinal disease Glomerular filtrate estimate CockcroftGault , 30 ml/min Any follow clinical state : ) High blood pressure define systolic blood pressure high 140 mmHg diastolic blood pressure high 90 mmHg associate proteinuria 0.31 g/day and/or microhematuria . b ) Proteinuria high 1g/day Women childbearing age follow suitable contraceptive method , negative pregnancy test need inclusion study Serology positive HIV hepatitis B infection ( define positive HbsAg antigen ) hepatitis C infection ( defined viral RNA detection ) Treatment steroids immunosuppressor two previous year Evidence active infection time inclusion study Pregnancy breastfeeding time inclusion study Estimated glomerular filtration &lt; 30 ml/min , bilirubin &gt; 2 mg/dl , ALT AST two time higher normal upper limit Diabetes Mellitus , define patient treated insulin oral antidiabetic glycemias high 140 mg/dl two episode Poor control high blood pressure ( define systolic blood pressure great 160 mm Hg diastolic blood pressure great 100 mm Hg , take 3 antihypertensive ) evidence suspicion renovascular disease Thrombocytopenia le 100,000 /mm3 total neutrophil value lower 2000 /mm3 triglyceride value &gt; 400 mg/dL ( 4.6 mmol/L ) cholesterol &gt; 300 mg/dL ( 7.8 mmol/L ) LDL &gt; 200 mg/dL IgA nephropathy systemic form , i.e. , Sch√∂nleinHenoch purpura , IgA nephropathy secondary form , postrenal transplant IgA nephropathy recurrence , case present form rapidly progressive renal failure case presence cellular crescent 50 % glomerulus exclude History cancer previous 5 year , exception skin basocellular carcinoma uterine situ carcinoma ( completely remove ) Know intolerance Sirolimus macrolides</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Nephropathy , IGA</keyword>
	<keyword>Pilot trial</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>Rapamune</keyword>
</DOC>